Biotechnology and Medical Research (TRBC)

Consort, Opiant to develop nasal spray for opioid overdose treatment

Consort, Opiant to develop nasal spray for opioid overdose treatment

Published 10/09/2018

(Reuters) - Britain’s Consort Medical Plc said on Monday it had agreed to develop a nasal spray for treating opioid overdoses with specialty pharmaceutical company [more…]

Agios names former Celgene executive Jacqualyn Fouse as next CEO

Agios names former Celgene executive Jacqualyn Fouse as next CEO

Published 04/09/2018

(Reuters) - Agios Pharmaceuticals Inc on Tuesday said former Celgene Corp executive Jacqualyn Fouse would be its next chief executive officer, replacing longtime CEO David [more…]

Insurance tactic drags down U.S. drug prices in second quarter:…

Insurance tactic drags down U.S. drug prices in second quarter:…

Published 04/09/2018

NEW YORK (Reuters) - U.S. drug prices fell again in the second quarter, likely due to a new tactic insurers are using to limit financial [more…]

Scientists unpick how cannabis component may fight psychosis

Scientists unpick how cannabis component may fight psychosis

Published 30/08/2018

LONDON (Reuters) - British scientists have unraveled how a non-intoxicating component of cannabis acts in key brain areas to reduce abnormal activity in patients at [more…]

Novartis’s Kymriah wins EU approval for blood cancer treatment

Novartis’s Kymriah wins EU approval for blood cancer treatment

Published 27/08/2018

ZURICH (Reuters) - Novartis received European approval for Kymriah, its gene-modifying therapy for blood cancer, but said its introduction will vary from country to country [more…]

FDA approves Teva’s generic of Mylan’s EpiPen

FDA approves Teva’s generic of Mylan’s EpiPen

Published 18/08/2018

(Reuters) - The U.S. Food and Drug Administration on Thursday approved Teva Pharmaceutical Industries Ltd’s generic version of Mylan NV’s life-saving allergy injection, EpiPen, at [more…]

China sacks six senior officials at food and drug regulator over…

China sacks six senior officials at food and drug regulator over…

Published 18/08/2018

SHANGHAI (Reuters) - China said on Saturday it has sacked six senior officials at its food and drug regulator after a safety scandal at vaccine [more…]

Eisai/Biogen to advance Alzheimer’s drug, provide fresh hope

Eisai/Biogen to advance Alzheimer’s drug, provide fresh hope

Published 03/08/2018

(In this July 24th story, corrects paragraphs 3 and 16 to clarify that Eisai executive said the trial generated positive, rather than effective, results at [more…]

Sienna Biopharma sinks after acne drug fails two trials

Sienna Biopharma sinks after acne drug fails two trials

Published 30/07/2018

(Reuters) - Sienna Biopharmaceuticals Inc said on Monday two pivotal trials testing its lead experimental treatment for acne did not meet their main goals, sending [more…]

RedHill BioPharma has positive results from Crohn’s disease trial

RedHill BioPharma has positive results from Crohn’s disease trial

Published 30/07/2018

TEL AVIV (Reuters) - Israel’s RedHill Biopharma said on Monday it had positive safety and efficacy results from a late-stage clinical trial with its treatment [more…]